Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation.

about

Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation.

Item

http://www.wikidata.org/entity/Q47561771

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Repurposing of the CDK inhibit ...... therapy via redox modulation.

@en

Repurposing of the CDK inhibit ...... therapy via redox modulation.

@nl

type

Item

label

Repurposing of the CDK inhibit ...... therapy via redox modulation.

@en

Repurposing of the CDK inhibit ...... therapy via redox modulation.

@nl

prefLabel

Repurposing of the CDK inhibit ...... therapy via redox modulation.

@en

Repurposing of the CDK inhibit ...... therapy via redox modulation.

@nl

P1476

Repurposing of the CDK inhibit ...... r therapy via redox modulation

@en

P2093

Andrea Z Tuckett

http://www.w3.org/2001/XMLSchema#string

Johannes L Zakrzewski

http://www.w3.org/2001/XMLSchema#string

Myles Fennell

http://www.w3.org/2001/XMLSchema#string

Ralph Garippa

http://www.w3.org/2001/XMLSchema#string

P2860

NRF2 cysteine residues are critical for oxidant/electrophile-sensing, Kelch-like ECH-associated protein-1-dependent ubiquitination-proteasomal degradation, and transcription activation

Antioxidant responses and cellular adjustments to oxidative stress

Serine and glycine metabolism in cancer

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy

Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer

Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia

Modulation of oxidative stress as an anticancer strategy

P2888

s10637-017-0557-6

P304

590-600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10637-017-0557-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hsiu-Yu Liu

P577

2018-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29297149

http://www.w3.org/2001/XMLSchema#string